Skip to main content

VAN ECK ASSOCIATES CORP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 869178 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$40,737,114
-$7,617,787 QoQ
Shares Held
65,332
+4.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#142
of 1,327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VAN ECK ASSOCIATES CORP holds $344,568,608 across 24 Biotechnology names. REGN ranks #2 (11.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
65,332 $40,737,114

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,737,114 65,332
2026-03-31 $48,354,901 62,584
2025-12-31 $50,090,502 64,895
2025-09-30 $31,778,375 56,518
2025-06-30 $29,672,475 56,519
2025-03-31 $35,026,619 55,227
2024-12-31 $41,694,811 58,533
2024-09-30 $54,728 58,136
2024-06-30 $56,118,695 53,394
2024-03-31 $53,263,233 55,339
2023-12-31 $56,506,543 64,337
2023-09-30 $46,767,170 56,828
2023-06-30 $43,266,885 60,215
2023-03-31 $48,289,545 58,770
2022-12-31 $37,158,899 51,503
2022-09-30 $45,917,318 66,656
2022-06-30 $37,552,123 63,526
2022-03-31 $44,039,571 63,056
2021-12-31 $41,236,992 65,298
2021-09-30 $36,620,046 60,511
2021-06-30 $36,640,223 65,600
2021-03-31 $29,311,495 61,951
2020-12-31 $28,104,440 58,174
2020-09-30 $27,566,925 49,246
2020-06-30 $27,987,540 44,877
2020-03-31 $18,256,185 37,388